Avestar Capital’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,495
Closed -$335K 347
2022
Q1
$335K Sell
5,495
-63,887
-92% -$3.81M 0.05% 287
2021
Q4
$4.57M Sell
69,382
-1,371
-2% -$87.8K 0.56% 41
2021
Q3
$4.44M Buy
70,753
+553
+0.8% +$35.3K 0.57% 41
2021
Q2
$4.22M Buy
70,200
+4,686
+7% +$271K 0.57% 47
2021
Q1
$3.94M Buy
65,514
+23,928
+58% +$1.33M 0.88% 21
2020
Q4
$2.27M Buy
41,586
+19,230
+86% +$1.01M 0.63% 30
2020
Q3
$1.16M Buy
+22,356
New +$1.08M 0.38% 57

Other funds holding IHI

Avestar Capital's IHI Position: Q2 2022 in Review

Avestar Capital sold out of iShares US Medical Devices ETF (IHI) in Q2 2022, closing a stake of 5,495 shares — an estimated $335K sold.

Avestar Capital first reported a position in IHI in Q3 2020 and held it in 7 quarters. The position peaked at $4.57M in Q4 2021. 592 funds tracked by Wall St. Rank hold IHI as of Q2 2022.

  • Avestar Capital reported no remaining iShares US Medical Devices ETF position as of Q2 2022 after selling out during the quarter.
  • Avestar Capital sold 5,495 iShares US Medical Devices ETF shares in Q2 2022, an estimated $335K.
  • Avestar Capital first reported a position in iShares US Medical Devices ETF in Q3 2020 and held it in 7 quarters.
  • Avestar Capital's iShares US Medical Devices ETF position peaked at $4.57M in Q4 2021.
  • 592 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2022.

Based on Avestar Capital's 13F filing for Q2 2022, filed 28 Jul 2022.